246 related articles for article (PubMed ID: 31710124)
1. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis.
Furuya S; Argemi J; Uehara T; Katou Y; Fouts DE; Schnabl B; Dubuquoy L; Belorkar A; Vadigepalli R; Kono H; Bataller R; Rusyn I
Alcohol Clin Exp Res; 2020 Jan; 44(1):87-101. PubMed ID: 31710124
[TBL] [Abstract][Full Text] [Related]
2. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.
Furuya S; Cichocki JA; Konganti K; Dreval K; Uehara T; Katou Y; Fukushima H; Kono H; Pogribny IP; Argemi J; Bataller R; Rusyn I
Toxicol Sci; 2019 Aug; 170(2):427-437. PubMed ID: 30517762
[TBL] [Abstract][Full Text] [Related]
3. Maternal obesogenic diet enhances cholestatic liver disease in offspring.
Thompson MD; Hinrichs H; Faerber A; Tarr PI; Davidson NO
J Lipid Res; 2022 May; 63(5):100205. PubMed ID: 35341737
[TBL] [Abstract][Full Text] [Related]
4. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation.
Blaya D; Coll M; Rodrigo-Torres D; Vila-Casadesús M; Altamirano J; Llopis M; Graupera I; Perea L; Aguilar-Bravo B; Díaz A; Banales JM; Clària J; Lozano JJ; Bataller R; Caballería J; Ginès P; Sancho-Bru P
Gut; 2016 Sep; 65(9):1535-45. PubMed ID: 27196584
[TBL] [Abstract][Full Text] [Related]
5. NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis.
Ji X; Li L; Lu P; Li X; Tian D; Liu M
Biochem Biophys Res Commun; 2020 Jul; 528(3):485-492. PubMed ID: 32507279
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA expression profile of liver tissues in an EtOH-induced mouse model of alcoholic hepatitis.
Meng H; Wang L; You H; Huang C; Li J
Eur J Pharmacol; 2019 Nov; 862():172642. PubMed ID: 31493407
[TBL] [Abstract][Full Text] [Related]
7. A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD
Kang H; Kim MB; Park YK; Lee JY
J Nutr Biochem; 2022 Jan; 99():108852. PubMed ID: 34525389
[TBL] [Abstract][Full Text] [Related]
8. New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver disease.
Cheng Y; Lin S; Ren T; Zhang J; Shi Y; Chen Y; Chen Y
Exp Anim; 2023 Aug; 72(3):389-401. PubMed ID: 37019681
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis.
Takeuchi M; Vidigal PT; Guerra MT; Hundt MA; Robert ME; Olave-Martinez M; Aoki S; Khamphaya T; Kersten R; Kruglov E; de la Rosa Rodriguez R; Banales JM; Nathanson MH; Weerachayaphorn J
Gut; 2021 Feb; 70(2):342-356. PubMed ID: 33214166
[TBL] [Abstract][Full Text] [Related]
10. IL-8 signaling is up-regulated in alcoholic hepatitis and DDC fed mice with Mallory Denk Bodies (MDBs) present.
Liu H; French BA; Nelson TJ; Li J; Tillman B; French SW
Exp Mol Pathol; 2015 Oct; 99(2):320-5. PubMed ID: 26260904
[TBL] [Abstract][Full Text] [Related]
11. Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than
Sheriff L; Khan RS; Saborano R; Wilkin R; Luu NT; Gunther UL; Hubscher SG; Newsome PN; Lalor PF
Dis Model Mech; 2020 Dec; 13(12):. PubMed ID: 33067186
[TBL] [Abstract][Full Text] [Related]
12. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
Pose E; Sancho-Bru P; Coll M
Methods Mol Biol; 2019; 1981():249-257. PubMed ID: 31016659
[TBL] [Abstract][Full Text] [Related]
13. Time-series metabolomics insights into the progressive characteristics of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver fibrosis in mice.
Li Y; Xue H; Fang S; Wang G; Wang Y; Wang T; Shi R; Wu J; Ma Y
J Pharm Biomed Anal; 2021 May; 198():113986. PubMed ID: 33690095
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
[TBL] [Abstract][Full Text] [Related]
15. Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.
Kim KH; Sung HJ; Lee WR; An HJ; Kim JY; Pak SC; Han SM; Park KK
Toxins (Basel); 2015 Aug; 7(9):3372-87. PubMed ID: 26308055
[TBL] [Abstract][Full Text] [Related]
16. Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway.
Jiang B; Yuan G; Wu J; Wu Q; Li L; Jiang P
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166320. PubMed ID: 34896545
[TBL] [Abstract][Full Text] [Related]
17. E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network.
Zhang Y; Xu N; Xu J; Kong B; Copple B; Guo GL; Wang L
Hepatology; 2014 Sep; 60(3):919-30. PubMed ID: 24619556
[TBL] [Abstract][Full Text] [Related]
18. CsHscB Derived from a Liver Fluke
Yu Q; Koda S; Xu N; Li J; Wang JL; Liu M; Liu JX; Zhang Y; Yang HM; Zhang BB; Li XY; Li XC; Tang RX; Zheng KY; Yan C
Curr Mol Med; 2024; 24(4):505-515. PubMed ID: 37076961
[TBL] [Abstract][Full Text] [Related]
19. MiR-451a ameliorates alcoholic hepatitis via repressing HDAC8-mediated proinflammatory response.
Du B; Tan XH; Cheng L; Wang F; Zhang HF
Kaohsiung J Med Sci; 2020 Nov; 36(11):904-910. PubMed ID: 32643864
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11 drives human and mouse alcohol-related liver disease.
Effenberger M; Widjaja AA; Grabherr F; Schaefer B; Grander C; Mayr L; Schwaerzler J; Enrich B; Moser P; Fink J; Pedrini A; Jaschke N; Kirchmair A; Pfister A; Hausmann B; Bale R; Putzer D; Zoller H; Schafer S; Pjevac P; Trajanoski Z; Oberhuber G; Adolph T; Cook S; Tilg H
Gut; 2023 Jan; 72(1):168-179. PubMed ID: 35365572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
